U Frei has received honoraria from Shire for consultancy and presentations.
This is important because many members of the Group have at one time or another entered into financial relations with pharmaceutical companies for a range of different activities including consultancy, advice, presentations to meetings, as well as funding for trials and other studies.
BS has received consultancy fees and honoraria for presentations from the GlaxoSmithKline group of companies and Novartis.
MJP received payment for consultancy, lectures, development of educational presentations and membership of advisory boards, and his institution received research grants and payment for consultancy, from various companies in the pharmaceutical industry, including those producing rotavirus vaccines; i.e. the GlaxoSmithKline group of companies and Sanofi-Pasteur MSD.
Dr Brian Cuthbertson has received honoraria for presentations and for consultancies from Eli Lilly and Company.
A.C. has received honoraria for presentation at workshops, consultancy and advisory board, or research grants from Abbott, Boehringer-Inghelheim, Bristol Myers Squibb, Gilead Sciences, Glaxo-Smith Kline, Merck, Pfizer, Roche, and Tibotec (Johnson & Johnson).
YY received travel grants, honoraria for presentations at workshops and consultancy honoraria from Abbott, Bristol-Myers Squibb, Gilead, Merck, Roche, Tibotec and ViiV Healthcare.
YY has received honoraria for presentation at workshops and consultancy honoraria from Bristol-Myers Squibb, Glaxo-SmithKlineithKline, Merck, Pfizer, Roche and Tibotec.
B. M. has received grants from TEVA-Pharma, Desitin, Boehringer Ingelheim, GE Healthcare and honoraria for consultancy from Bayer Schering Pharma AG, AbbVie, TEVA-Pharma, for presentations from GlaxoSmithKline, Orion Pharma, TEVA-Pharma.
MK has received consultancy fees and honoraria for advisory activities and presentations from Novartis, the GlaxoSmithKline group of companies and AstraZeneca.
